floxacillin has been researched along with Eczema, Atopic in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Colven, R; Kirby, P; Olson, J; Robles, DT | 1 |
Hill, SE; Rademaker, M; Yung, A | 1 |
Behrendt, H; Vollmert, C | 1 |
Broberg, A; Faergemann, J | 1 |
Ashcroft, C; Connor, PJ; David, TJ; Ewing, CI; Gibbs, AC; Jones, GA | 1 |
Baerlocher, K; Hochreutener, H; Huwyler, T; Schopfer, K; Seger, R; Wüthrich, B | 1 |
2 trial(s) available for floxacillin and Eczema, Atopic
Article | Year |
---|---|
Topical antimycotic treatment of atopic dermatitis in the head/neck area. A double-blind randomised study.
Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Colony Count, Microbial; Dermatitis, Atopic; Double-Blind Method; Female; Floxacillin; Follow-Up Studies; Hair Preparations; Head; Humans; Hydrocortisone; Ketoconazole; Malassezia; Male; Miconazole; Middle Aged; Neck; Placebos; Skin Tests | 1995 |
Flucloxacillin in the treatment of atopic dermatitis.
Topics: Adolescent; Child; Child, Preschool; Dermatitis, Atopic; Double-Blind Method; Floxacillin; Humans; Infant; Patient Compliance; Penicillin Resistance; Penicillins; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Treatment Outcome | 1998 |
4 other study(ies) available for floxacillin and Eczema, Atopic
Article | Year |
---|---|
Kaposi varicelliform eruption (eczema herpeticum).
Topics: Acyclovir; Adult; Antiviral Agents; Codeine; Dermatitis, Allergic Contact; Dermatitis, Atopic; Diagnostic Errors; Disease Susceptibility; Facial Dermatoses; Female; Floxacillin; Herpesvirus 1, Human; Humans; Kaposi Varicelliform Eruption; Morphine; Prednisone; Respiratory Hypersensitivity; Staphylococcal Skin Infections; Valacyclovir; Valine | 2008 |
Prevalence of Staphylococcus aureus and antibiotic resistance in children with atopic dermatitis: a New Zealand experience.
Topics: Anti-Bacterial Agents; Child; Dermatitis, Atopic; Drug Resistance, Microbial; Female; Floxacillin; Humans; Male; New Zealand; Prevalence; Risk Factors; Severity of Illness Index; Staphylococcal Infections; Staphylococcus aureus | 2011 |
Bactericidal activity of flucloxacillin against Staphylococcus aureus in primary keratinocyte cultures of lesional and unaffected skin of patients suffering from atopic dermatitis.
Topics: Anti-Bacterial Agents; Biopsy; Cell Differentiation; Cell Division; Cell Survival; Cells, Cultured; Dermatitis, Atopic; Disinfection; Dose-Response Relationship, Drug; Floxacillin; Humans; In Vitro Techniques; Keratinocytes; Skin; Staphylococcal Infections; Staphylococcus aureus; Time Factors | 2005 |
Variant of hyper-IgE syndrome: the differentiation from atopic dermatitis is important because of treatment and prognosis.
Topics: Abscess; Adolescent; Antibodies, Bacterial; Dermatitis, Atopic; Diagnosis, Differential; Eosinophilia; Floxacillin; Humans; Immunoglobulin E; Male; Prognosis; Recurrence; Staphylococcal Skin Infections; Staphylococcus; Syndrome | 1991 |